戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 y virus (HIV) and is associated with reduced systemic inflammation.
2 duals with lower SES showed higher levels of systemic inflammation.
3  the relationship between SES and markers of systemic inflammation.
4 cterial colonization and potentially reflect systemic inflammation.
5  failure (HF) is associated with measures of systemic inflammation.
6 hese mice spontaneously develop a severe and systemic inflammation.
7 d by ischaemia-reperfusion, toxic injury and systemic inflammation.
8 c UBA1 isoform homologue in zebrafish caused systemic inflammation.
9  anti-inflammatory molecules and increase in systemic inflammation.
10 esicles (OMVs) that are capable of mediating systemic inflammation.
11 notype of asthma associated with obesity and systemic inflammation.
12 -related asthma symptoms, albuterol use, and systemic inflammation.
13 acrophages to produce IL-1beta, thus driving systemic inflammation.
14 NT-proBNP, kidney function and of markers of systemic inflammation.
15 a-1-Acid glycoprotein at 15 mo characterized systemic inflammation.
16  critical cells for the control of local and systemic inflammation.
17 en shown to play important roles in limiting systemic inflammation.
18 serum cytokines were assessed as measures of systemic inflammation.
19 distinguish between sepsis and noninfectious systemic inflammation.
20 f foamy macrophages, hepatosplenomegaly, and systemic inflammation.
21 t few studies adjust for dietary intakes and systemic inflammation.
22  a proportion that correlates inversely with systemic inflammation.
23 umor and bone marrow glucose uptake and host systemic inflammation.
24 S with AMD is, at least in part, a result of systemic inflammation.
25 s, which may spread to produce more advanced systemic inflammation.
26 lerance and insulin sensitivity with reduced systemic inflammation.
27  of IL-6TS-inducible genes in the absence of systemic inflammation.
28 me have been linked to increased frailty and systemic inflammation.
29 isease of the cardiac muscle associated with systemic inflammation.
30 sm such as hyperthermia, endotoxemia, and/or systemic inflammation.
31 s of the antibiotics are driven by increased systemic inflammation.
32 omotes host-microbiota mutualism, preventing systemic inflammation.
33 tality in 48 to 72 h due to robust local and systemic inflammation.
34 ers (CCR1, MAPK14, ICAM1) leads to increased systemic inflammation.
35  the oral microbiota triggered by RA-induced systemic inflammation.
36 n ApoE(-/-)MHCII(-/-) mice indicated reduced systemic inflammation.
37 lleviating hepatic and renal dysfunction and systemic inflammation.
38 er activation is not limited to induction by systemic inflammation.
39 o accomplish this are nonspecific and elicit systemic inflammation.
40 infection-positive versus infection-negative systemic inflammation.
41                  No changes were observed in systemic inflammation.
42 e actions of these statins on both joint and systemic inflammation.
43  in Apoe (-/-) mice by regulating lesion and systemic inflammation.
44 ted a significant decrease in >/=1 marker of systemic inflammation.
45 ease in exercise performance observed during systemic inflammation.
46 g the effect of prebiotics and synbiotics on systemic inflammation.
47 ficiencies in immune responses and increased systemic inflammation.
48 infected neutrophilic RA was associated with systemic inflammation.
49 is of neurological disorders following acute systemic inflammation.
50 rts protective actions reducing vascular and systemic inflammation.
51  levels, as well as reductions in airway and systemic inflammation.
52 ght loss, atrophy of adipose tissue (AT) and systemic inflammation.
53 nuated by adjustment for baseline markers of systemic inflammation.
54 is characterised by intermittent hypoxia and systemic inflammation.
55 ress, myocardial injury, renal function, and systemic inflammation.
56  cells and/or correcting dysbiosis to dampen systemic inflammation.
57 immunoassay (Olink) and used to recapitulate systemic inflammation.
58 ) has increasingly been linked to heightened systemic inflammation.
59 , clinical stage, and elevated biomarkers of systemic inflammation.
60    Normal aging is accompanied by escalating systemic inflammation.
61 s that could be associated to improvement in systemic inflammation.
62 otential reduction in LRNC with treatment of systemic inflammation.
63 lood vessels and are accompanied by aberrant systemic inflammation.
64 ely progressing brain dysfunction induced by systemic inflammation.
65 okine responses to restimulation, it reduced systemic inflammation.
66  a potential approach to treating the severe systemic inflammation.
67 toms during the course of a fever, a sign of systemic inflammation(1,2).
68 uman sepsis, old mice demonstrated low-grade systemic inflammation 14 days after cecal ligation and p
69 )-which comprises multiorgan dysfunction and systemic inflammation(2-13).
70  In the cecal ligation and puncture model of systemic inflammation, a dramatic decrease of cytokine p
71  stress has been widely proposed to increase systemic inflammation, a pathway that may link stress wi
72                                              Systemic inflammation accompanied by a "cytokine storm,"
73  brain perfusion, catecholamine release, and systemic inflammation after severe hemorrhagic shock in
74       Increasing evidence has suggested that systemic inflammation along with local brain inflammatio
75 ic inflammation.SIGNIFICANCE STATEMENT Acute systemic inflammation alters behavior and produces dispr
76 ion of CLEC-2 but not GPVI leads to enhanced systemic inflammation and accelerated organ injury in tw
77 -/-) microbiota into Ldlr(-/-) mice enhances systemic inflammation and accelerates atherogenesis.
78 the cytokine interleukin-6 in vivo prevented systemic inflammation and ameliorated clinical disease.
79 ed WT mice resulted in increased severity of systemic inflammation and appearance of sJIA-like sympto
80 d significantly ameliorates their underlying systemic inflammation and autoimmunity.
81         We hypothesized that obesity-related systemic inflammation and B-cell stress could exacerbate
82 tent with the notion that obesity-associated systemic inflammation and B-cell stress lowers the thres
83 ffer therapeutic opportunities to ameliorate systemic inflammation and brain injury after stroke.
84 dy), we found that albumin treatment reduced systemic inflammation and cardiocirculatory dysfunction
85 racteristics of the human disease, including systemic inflammation and cartilage dysplasia, but the m
86 inflammatory diseases, which cause low-grade systemic inflammation and contribute to several common c
87 We conclude that circulating LPS can promote systemic inflammation and contribute to the development
88 ociated with increased circulating levels of systemic inflammation and endothelial dysfunction biomar
89 e suppressing circulating CD4(+) T cells and systemic inflammation and enhancing tissue neovasculariz
90 neural substrate of cold-seeking behavior in systemic inflammation and expands the functional topogra
91 obiota configuration that is associated with systemic inflammation and has a high prevalence in loose
92 ween pediatric sepsis and infection-negative systemic inflammation and hence can potentially improve
93 ratio (MLR) are respectively associated with systemic inflammation and immune suppression and have be
94 Ss broadly to include life/organ-threatening systemic inflammation and immunopathology regardless of
95 sceral adiposity is strongly associated with systemic inflammation and increased cardiometabolic risk
96       SAVI patients present with early-onset systemic inflammation and interstitial lung disease, res
97 P) is a biomarker used clinically to measure systemic inflammation and is reproducibly increased in a
98 ets for intervention to suppress CKD-related systemic inflammation and its consequences.
99 lso assessed in two in vivo models including systemic inflammation and local brain inflammation.
100  protective factor in the CNS in response to systemic inflammation and may be a potential candidate f
101 ch from BHD to mOL-HDF significantly reduced systemic inflammation and miR-223 expression in plasma E
102  promising new treatment concept to decrease systemic inflammation and mortality of sepsis.
103                 Biomarkers of intestinal and systemic inflammation and mucosal integrity were highly
104 t mice were protected from developing severe systemic inflammation and multi-organ injury following t
105 ndrome coronavirus-2 can induce uncontrolled systemic inflammation and multiple organ failure.
106 on cause of death in trauma due to excessive systemic inflammation and multiple organ failure.
107 al peripheral proinflammatory insult-induced systemic inflammation and normalized compromised blood-b
108 ease (iMCD) is a rare hematologic illness of systemic inflammation and organ dysfunction, with unknow
109 eing a mild self-limited illness to one with systemic inflammation and organ failure.
110 rdial infarction, stroke, and sepsis trigger systemic inflammation and organism-wide complications th
111 ulating inflammatory cytokines, may link the systemic inflammation and poor T cell function character
112                    In addition to decreasing systemic inflammation and providing glycemic control wit
113 ggesting its role in nonatopic TH1-polarized systemic inflammation and pulmonary function deficits fo
114 dy was to determine the relationship between systemic inflammation and quality of life in patients wi
115 alarmin high mobility group box 1 protein in systemic inflammation and remote organ injury after trau
116  content in blood, thereby helping to reduce systemic inflammation and reverse insulin resistance.
117 asured C-reactive protein (CRP), a marker of systemic inflammation and risk of inflammatory disease,
118                                              Systemic inflammation and sarcopenia are easily evaluate
119 iting neuroinflammation through reduction of systemic inflammation and standardized neuroprotection p
120  a reciprocal relationship between low-grade systemic inflammation and stress exposure towards increa
121                                Biomarkers of systemic inflammation and those for astrocyte and glial
122 otential for platelets in the development of systemic inflammation and thrombosis in SARS-CoV-2-infec
123 5), when systemically administered, triggers systemic inflammation and toxicity, with the liver being
124 amaging inflammatory cytokines, resulting in systemic inflammation and vascular dysfunction.
125 , we report that metabolic fasting increased systemic inflammation and worsened survival in experimen
126  variable and can include moderate to severe systemic inflammation and/or marked systemic immune supp
127 ced survival as well as reduced weight loss, systemic inflammation, and bacterial burden.
128 t the maintenance of the intestinal barrier, systemic inflammation, and glucose metabolism.
129  of 25(OH)D and PTH with beta-cell function, systemic inflammation, and kidney function apparently di
130 ng left ventricular and pulmonary pathology, systemic inflammation, and neurohormonal activation.
131 n transplants, and reaction to local injury, systemic inflammation, and regeneration.
132  with hydrocephalus, necrotizing cellulitis, systemic inflammation, and respiratory failure.
133 f breast tumours in dictating pro-metastatic systemic inflammation, and set the stage for personalize
134 cted third molars are associated with higher systemic inflammation, and their removal may represent a
135 ient deficiency risk independent of diet and systemic inflammation, and whether it mediates the relat
136 ociated altered metabolic profile, increased systemic inflammation, and, in men, poorer liver functio
137 s during TB-IRIS and their relationship with systemic inflammation are not fully understood.
138 sis and NAFLD the gut microbiota profile and systemic inflammation are significantly correlated and c
139                      Using endotoxin-induced systemic inflammation as a model, we found that electroa
140  is evidence that there are other drivers of systemic inflammation as measured by CRP.
141  is evidence that there are other drivers of systemic inflammation as measured by CRP.
142 etaflammation refers to a chronic, low-grade systemic inflammation as opposed to the classical transi
143 as assessed on a patient-reported scale) and systemic inflammation (as shown by an elevated C-reactiv
144                                              Systemic inflammation associated with brain death (BD) d
145 tand the effects of psoriasis medications on systemic inflammation associated with cardiovascular ris
146                            Septic shock is a systemic inflammation associated with cell metabolism di
147 in older adults, for example, it reduces the systemic inflammation associated with chronic age-relate
148 ry one, thereby resolving both the local and systemic inflammation associated with periodontal diseas
149 st that increases in FIB-4 may be reflecting systemic inflammation associated with poor outcomes.
150 hocyte ratio (NLR) is a desirable measure of systemic inflammation because it is easily calculated fr
151 cyte ratio (NLR) was used as an indicator of systemic inflammation before and after surgery.
152 hilic lipid-polymer conjugates that suppress systemic inflammation but provoke potent lymph-node immu
153                         Hypertension induces systemic inflammation, but its impact on the outcome of
154 vasculature responds within minutes to acute systemic inflammation by upregulating the expression of
155                                              Systemic inflammation can affect the progression of some
156                                              Systemic inflammation can impair cognition with relevanc
157 ase 1 knockout (Trex1(-/-)) mice suffer from systemic inflammation caused largely by chronic activati
158                 KSHV-MCD is characterized by systemic inflammation caused, in part, by lytic replicat
159                                  Early life, systemic inflammation causes long-lasting changes in beh
160 on caused maternal hypothermia, bradycardia, systemic inflammation, cervical dilation, intra-amniotic
161 lopathy with onset in infancy (SAVI) develop systemic inflammation characterized by vasculopathy, int
162  Trigeminal nerve stimulation also decreased systemic inflammation compared with the vehicle.
163                                   Rationale: Systemic inflammation compromises the reparative propert
164 Results: Using IL-10 knockout mice mimicking systemic inflammation condition, we compared therapeutic
165 ve suggested that dysregulated localized and systemic inflammation contributes to the development and
166 pulmonary bypass surgery (infection-negative systemic inflammation control subjects) was recruited.
167 c disorder characterized by lymphadenopathy, systemic inflammation, cytopenias, and life-threatening
168 olving cytokine-induced lymphoproliferation, systemic inflammation, cytopenias, and life-threatening
169 to pathogen dissemination and intestinal and systemic inflammation during the oral route of infection
170                                              Systemic inflammation, endothelial dysfunction, hepatic
171                     In contrast, LPS-induced systemic inflammation enhanced Zip14-dependent zinc upta
172 reased LOY was associated with lower chronic systemic inflammation even after menopause.
173                          All four had marked systemic inflammation, fever and fluctuating radiologic
174                    Decoupling age-associated systemic inflammation from chronological aging by using
175 creased oral inflammatory load and increased systemic inflammation have an adverse effect on infant b
176      Links between microbial alterations and systemic inflammation have been demonstrated in chronic
177  play an important role in the regulation of systemic inflammation; however, the functional role of t
178 al complement complex levels and measures of systemic inflammation (i.e., CRP), cardiac function (i.e
179 ether with features of T-cell activation and systemic inflammation identified here support the view t
180  identify peripheral biomarkers representing systemic inflammation, impaired neuroprotection, and ast
181  BCG (BCG-Bulgaria, InterVax) vaccination on systemic inflammation in a cohort of 303 healthy volunte
182 RR) ligands, and investigating the course of systemic inflammation in a prospective cohort of acute a
183 type-1 agonist, attenuated hyperglycemia and systemic inflammation in diabetic endotoxemic mice.
184 imental diabetes increased hyperglycemia and systemic inflammation in experimental sepsis.
185 mmatory beta-glucans efficacy at attenuating systemic inflammation in health, and renal and vascular
186 M17- and nSMase2 gene expression attenuating systemic inflammation in health, and renal injury and ao
187 d support to a hypothesis implicating global systemic inflammation in HF with preserved ejection frac
188 nously, or per rectum; were on biomarkers of systemic inflammation in humans; and performed meta-anal
189 that plasmodial DNA is the primary driver of systemic inflammation in malaria, both within the phagol
190 tially ameliorates Treg cell dysfunction and systemic inflammation in O-GlcNAc deficient mice.
191                                 We inhibited systemic inflammation in old subjects by means of pretre
192 latory dysfunction, portal hypertension, and systemic inflammation in patients with decompensated cir
193 ith HF.CONCLUSIONThese findings suggest that systemic inflammation in patients with HF is causally li
194 s which improves dyslipidemia and markers of systemic inflammation in patients with Metabolic Syndrom
195 renine pathway of tryptophan metabolism, and systemic inflammation in people with HIV (PWH).
196 h several reports have documented heightened systemic inflammation in posttraumatic stress disorder (
197                                Non-resolving systemic inflammation in TBDM comorbidity could reflect
198 hritis model and in IL-1beta- or LPS-induced systemic inflammation in vivo, IL-1R2(-/-) mice were cre
199  evidence supports the active involvement of systemic inflammation, in addition to local brain inflam
200 nd I-FABP correlated with several markers of systemic inflammation, including high-sensitivity C-reac
201 diated aTreg depletion resulted in increased systemic inflammation, increased inflammatory macrophage
202                   It has been suggested that systemic inflammation increases the risk of age-related
203                                              Systemic inflammation independently predicts future card
204                            Here we show that systemic inflammation, induced by bacterial LPS, produce
205                                      Whether systemic inflammation-induced acute dysfunction and acut
206            Thus "bioenergetic stress" drives systemic inflammation-induced dysfunction.
207 rols (n = 50), we measured parasite biomass, systemic inflammation (interleukin 6 [IL-6]), endothelia
208  sequential events during the advancement of systemic inflammation into the CNS and facilitate to und
209                                              Systemic inflammation is a hallmark of commonly encounte
210                    Infection-triggered acute systemic inflammation is able to induce neuroinflammatio
211                                  Evidence of systemic inflammation is also present in some patients w
212                                              Systemic inflammation is increased in patients who devel
213                                              Systemic inflammation is known to increase the risk for
214                            Chronic low grade systemic inflammation is linked to impaired lung functio
215                                              Systemic inflammation is present during and serves as a
216                            Cancer-associated systemic inflammation is strongly linked to poor disease
217                                       In RA, systemic inflammation is thought to directly contribute
218        However, the origin of age-associated systemic inflammation is unknown.
219  well as an advocated in vivo model of acute systemic inflammation is unknown.
220 nt role of IL-1beta in controlling local and systemic inflammation, its overall regulation is still n
221                                              Systemic inflammation levels in Bact2-enterotyped indivi
222 erial dissemination from the oral cavity and systemic inflammation linked to IDT can induce a state o
223 nd platelet aggregation were impaired due to systemic inflammation, liver failure, anticoagulants (he
224                               In addition to systemic inflammation, local arterial inflammation, driv
225 r1/Per2 is beneficial to counteract elevated systemic inflammation, lung tissue inflammation, and iro
226      These data aid our understanding of how systemic inflammation may augment the progression of neu
227                                              Systemic inflammation may influence trajectories of depr
228                       We measured markers of systemic inflammation, monocyte activation, and gut inte
229                                          The systemic inflammation most likely occurs as a consequenc
230      Emerging evidence implicates airway and systemic inflammation, neuroimmune interactions, and eff
231      Emerging evidence implicates airway and systemic inflammation, neuroimmune interactions, as well
232                             Neither maternal systemic inflammation nor placental (fetal) inflammation
233 on contributes to inflammatory arthritis and systemic inflammation not only in RA, but possibly also
234 fail to grow and die prematurely, displaying systemic inflammation, nutrient malabsorption and decrea
235 rily localized to skin lesions and lacks the systemic inflammation of moderate and severe disease.
236        Such 'leaky gut' conditions result in systemic inflammation, of which a hallmark is increased
237  distress syndrome (stage 3) associated with systemic inflammation often termed a "cytokine storm." B
238 = 0.23, p = 0.01) suggesting that actions of systemic inflammation on amygdala emotional reactivity p
239 our findings may suggest a different role of systemic inflammation on the risk of Parkinson disease c
240 atures: airway neutrophilia, obesity-related systemic inflammation, or in some cases, few signs of im
241  arterial endothelial function or stiffness, systemic inflammation, or lipid profile, but resulted in
242 matic adverse events, baseline intestinal or systemic inflammation, or vitamin D status.
243                         We hypothesized that systemic inflammation per se can significantly prolong Q
244 ecent findings suggest that an overexuberant systemic inflammation plays a primary role in ACLF progr
245 porary antihyperglycemic agents, by reducing systemic inflammation postbariatric surgery, or by modul
246                      In the absence of Spop, systemic inflammation proceeded in an unresolved manner,
247                  The data suggest that acute systemic inflammation produces both reversible cognitive
248  impact of age on the overall changes in the systemic inflammation profiles in subpopulation of TB pa
249                     During acute infections, systemic inflammation rapidly induces cytokine-mediated
250                                              Systemic inflammation reduced microglial clearance of am
251                                              Systemic inflammation, reflected by increased plasma con
252 clear magnetic resonance composite marker of systemic inflammation, reflects serum concentration and
253 e injured brain sends out signals to trigger systemic inflammation remains unclear.
254  as lipopolysaccharides (or endotoxin) cause systemic inflammation, resulting in a substantial global
255 hereas Ripk1(-/-) mice died postnatally from systemic inflammation, Ripk1(D325A/D325A) mice died duri
256 CE There is a slow yet significant uptick in systemic inflammation secondary to HIV infection that ha
257 port that caspase-8 is a central mediator of systemic inflammation, septic shock in the Plasmodium ch
258 nce microbial responsiveness while dampening systemic inflammation should be further explored for pot
259  Obese individuals with persistent low-grade systemic inflammation showed reduced leukocyte productio
260                                              Systemic inflammation (SI) is involved in the pathogenes
261 sms involved in hypothermia and fever during systemic inflammation (SI) remain largely unknown.
262 rved during lipopolysaccharide (LPS)-induced systemic inflammation (SI; at a septic-like model) in sp
263  rodent models of four common types of pain: systemic inflammation (sickness behaviour), post-surgica
264 havioral and cognitive consequences of acute systemic inflammation.SIGNIFICANCE STATEMENT Acute syste
265 h of these diseases are also associated with systemic inflammation, similar to HIV infection.
266 dy end points included changes in markers of systemic inflammation (soluble CD163 and CD14, and inter
267                 Following this pulmonary and systemic inflammation, spinal cord injury-immune depress
268 oimmunity appears to cause catatonia less by systemic inflammation than by the downstream effects of
269 ection in vivo is characterized by extensive systemic inflammation that can exacerbate infection by p
270          Obesity is accompanied by low-grade systemic inflammation that etiologically contributes to
271 of dysregulated immunometabolism and chronic systemic inflammation that intensifies virally induced h
272                   Sepsis is characterized by systemic inflammation that is caused by infection and by
273 cline of barrier integrity and the resulting systemic inflammation that occurs with aging.
274 on in the early phase after fracture reduced systemic inflammation, the recruitment of immune cells,
275 n is associated with platelet hyperactivity, systemic inflammation, thrombotic complications, and coa
276                                              Systemic inflammation through persistent monocyte activa
277 oluble cytokine that is directly involved in systemic inflammation through the regulation of the intr
278 ed carbon nanotubes (MWCNTs) causes indirect systemic inflammation through unknown pathways.
279 rate that deregulated necroptosis results in systemic inflammation, tissue fibrosis, and autoimmunity
280 Further study is needed to determine whether systemic inflammation truly drives SIRS in this populati
281 nregulation of adipocytokines and markers of systemic inflammation underlies vitamin D effects.
282  regulatory role for NK cells in CFA-induced systemic inflammation via a NKG2D-dependent control of a
283                                              Systemic inflammation was also associated with increased
284                                     Overall, systemic inflammation was directly linked to increased d
285                                              Systemic inflammation was lost on expression of a non-se
286 d prior to Il1b detection in the brain, when systemic inflammation was minimal.
287                                              Systemic inflammation was mitigated by propionate treatm
288 hile in mice IL-7 is known to play a role in systemic inflammation, we found that in humans IL-7 also
289                  Circulatory dysfunction and systemic inflammation were extremely unstable in many pa
290   The T cell-instructed IL-1beta resulted in systemic inflammation, whereas absence of TNFR or Fas si
291  most consistent with ICANS as a syndrome of systemic inflammation, which affects the brain through c
292 ng of sleep disturbance-induced increases in systemic inflammation, which can be viewed as an early e
293 homeostasis and the development of low-grade systemic inflammation, which increase the risk to develo
294 In addition, OSAS is considered as low-grade systemic inflammation, which is associated with a higher
295 el of endometriosis, IL-33 injections caused systemic inflammation, which manifested as an increase i
296 ng with acute severe respiratory failure and systemic inflammation who received either standard-of-ca
297 age, ineffective lung repair mechanisms, and systemic inflammation with associated organ dysfunction.
298                                              Systemic inflammation with high levels of pro-inflammato
299                                  They showed systemic inflammation with high levels of serum proinfla
300                  We statistically link early systemic inflammation with later local increases in infl

 
Page Top